A Study of 3D Doppler Echocardiography for More Accurate Measurement of Mitral Valve Regurgitation

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 14-008680
    Sponsor Protocol Number: 14-008680

About this study

The purpose of this study is to compare the value and practicality of using 3D color doppler echocardiography of the vena contracta area versus the standard 2D method when needing accurate measurement of mitral valve regurgitation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

 

Inclusion Criteria

  • Native mitral valve regurgitation (mild or greater) or mitral paravalvular leak (any degree of regurgitation)
  • Undergoing transesophageal echocardiography, with or without mitral paravalvular leak closure or percutaneous repair of the mitral valve (e.g. MitraClip) for clinical indications

 

Exclusion Criteria 

  • Inadequate image quality
  • Age <18 years

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Charles Bruce, M.D.

Closed for enrollment

.
CLS-20206527

Mayo Clinic Footer